Skip to main content

Table 2 Treatment related adverse events

From: Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study

  No. of Patients (n = 42)
  Grade I Grade II Grade III Grade IV
Haematological     
   Anaemia 3 (7.1%) 1 (2.4%) - -
   Neutropenia 5 (11.9%) 4 (9.5%) 3 (7.1%) 1 (2.4%)
Neuropathy 5 (11.9%) 6 (14.3) 3 (7.1%) -